Posts

Dying patients protest looming telehealth crackdown

The DEA wants to reinstate requirements that doctors see patients in person befo...

STAT+: Epic and Microsoft’s AI collaboration, Amazon an...

In the latest edition of STAT's Health Tech newsletter: Epic and Microsoft's AI ...

STAT+: Biden to tap head of National Cancer Institute t...

President Biden will nominate oncologist Monica Bertagnolli, director of the Nat...

From sheets to stacks, new nanostructures promise leap ...

Tokyo, Japan – Scientists from Tokyo Metropolitan University have successfully e...

Roche’s Polivy approved by FDA for treating common lymp...

Roche’s antibody drug Polivy has been given the green light by the Food and Drug...

GSK to Buy Bellus Health and Its Chronic Cough Drug for...

GSK has decided to pay $2 billion in cash to acquire Canadian-based medicine dev...

China clears CARsgen’s CT041 IND for pancreatic cancer

CT041 targets CLDN18.2 positive solid tumours by focusing on gastric cancer/gast...

AZ to terminate once-daily cotadutide program to focus ...

In a statement emailed to Endpoints News, AstraZeneca (AZ) disclosed intentions ...

Twist Bioscience and Astellas team up for antibody disc...

Astellas Pharma will use Twist Bioscience’s VHH antibody libraries to conduct re...

OTC Narcan will cost ‘less than $50’, company says

The maker of the first opioid treatment drug to be sold OTC has announced a pric...

FDA pushes Daiichi Sankyo’s quizartinib approval date b...

The drug’s application for patients in newly diagnosed TL3-ITD positive acute my...

DEA organises Drug Take Back Day to fight addiction

The US agency is organising events to encourage the safe disposal of prescriptio...

Orphalan launches Wilson disease therapy in US

Cuvrior is intended for treating adult patients who have stable Wilson disease.

Samyang and LG Chem partner to develop new mRNA-based c...

LG Chem will use Samyang’s NanoReady technology to develop new mRNA-based cancer...

Blue Water Vaccines agrees to buy Veru’s Entadfi capsul...

Entadfi combines finasteride and tadalafil to provide an effective treatment opt...

FDA pushes back on approving mirikizumab due to manufac...

Anti-interleukin therapies are generally prescribed as second-line or third-line...